These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28088882)

  • 1. Diabetes management strategies: can nanoparticles be used to therapeutically deliver insulin?
    Mazzucchelli S; Corsi F
    Ther Deliv; 2017 Feb; 8(2):49-51. PubMed ID: 28088882
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanotechnology in Insulin Delivery for Management of Diabetes.
    Bahman F; Greish K; Taurin S
    Pharm Nanotechnol; 2019; 7(2):113-128. PubMed ID: 30907328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Characterization of Hypoglycemic Nanoparticles for Oral Insulin Delivery.
    Zhang L; Zhang YX; Qiu JN; Li J; Chen W; Guan YQ
    Biomacromolecules; 2017 Dec; 18(12):4281-4291. PubMed ID: 29059517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral delivery of insulin via polyethylene imine-based nanoparticles for colonic release allows glycemic control in diabetic rats.
    Salvioni L; Fiandra L; Del Curto MD; Mazzucchelli S; Allevi R; Truffi M; Sorrentino L; Santini B; Cerea M; Palugan L; Corsi F; Colombo M
    Pharmacol Res; 2016 Aug; 110():122-130. PubMed ID: 27181095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine for diabetes treatment.
    Sung HW; Sonaje K; Feng SS
    Nanomedicine (Lond); 2011 Oct; 6(8):1297-300. PubMed ID: 22026374
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus.
    Mohsen AM
    Curr Drug Targets; 2019; 20(10):995-1007. PubMed ID: 30848199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of biodegradable polymeric systems for oral insulin delivery.
    Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
    Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
    Singh S; Kushwah V; Agrawal AK; Jain S
    Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
    Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
    Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering novel carriers for oral insulin tablets: a pharmacoinformatics approach.
    Seenivasagam R; Hemavathi K; Sivakumar G; Niranjan V
    Int J Bioinform Res Appl; 2013; 9(2):184-206. PubMed ID: 23467063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylic acid-based pH-sensitive hydrogels as potential oral insulin delivery systems.
    Demirdirek B; Uhrich KE
    J Drug Target; 2015; 23(7-8):716-24. PubMed ID: 26453167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric core-shell nanoparticles for therapeutics.
    Yang YY; Wang Y; Powell R; Chan P
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):557-62. PubMed ID: 16700894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation.
    Guha A; Biswas N; Bhattacharjee K; Sahoo N; Kuotsu K
    Drug Deliv; 2016 Nov; 23(9):3552-3561. PubMed ID: 27540687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in polymeric devices for oral insulin delivery.
    Babu VR; Patel P; Mundargi RC; Rangaswamy V; Aminabhavi TM
    Expert Opin Drug Deliv; 2008 Apr; 5(4):403-15. PubMed ID: 18426382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a novel structure for the oral delivery of insulin and the study of its effect on diabetic rats.
    Esmaeili A; Mousavi SN
    Life Sci; 2017 Oct; 186():43-49. PubMed ID: 28827153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of polymers ratio on insulin-loaded nanoparticles based on poly-epsilon-caprolactone and Eudragit RS for oral administration.
    Socha M; Sapin A; Damgé C; Maincent P
    Drug Deliv; 2009 Nov; 16(8):430-6. PubMed ID: 19839787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.